{"disease":{"id":"rheumatic-heart-disease","name":"Rheumatic heart disease","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":15,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"hydrocortisone-succinate","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-acetate","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-acetate","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celestone Soluspan","generic_name":"BETAMETHASONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"prednison","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednison","company_name":"Wen Zhang","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolone","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"hydrocortisone","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"prednisone","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"betamethasone","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"cortisol","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolon","indication_name":"Rheumatic heart disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":15,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05276999","title":"Rheumatic Heart Disease Community Streptococcal Treatment Program \"RESET\"","phase":"NA","overall_status":"COMPLETED","enrollment_count":66123,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT04936815","title":"Echocardiographic Screening of Pregnant Women During Antenatal Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9000,"lead_sponsor_name":"Thomas Pilgrim","has_results":false},{"nct_id":"NCT05991219","title":"Screening and Secondary Prevention Rheumatic Heart Disease Study","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Institute of Cardiovascular Diseases, Pakistan","has_results":false},{"nct_id":"NCT02832544","title":"INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4565,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT04780607","title":"Outcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT05250154","title":"Rheumatic Heart Disease Research and Screening in Nepal: A Feasibility Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2438,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT07065474","title":"Effectiveness of Edutainment-Based Interventions in Increasing Knowledge of Rheumatic Fever and Rheumatic Heart Disease Among School-Going Children in Nepal: Study Protocol for Colors to Save Hearts Quasi-Experimental Pretest-Posttest Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2400,"lead_sponsor_name":"Kathmandu Institute of Child Health","has_results":false},{"nct_id":"NCT05504928","title":"Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":2300,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT05895487","title":"Study on Efficacy, Safety and Durability of the UniLine Prosthesis in the Treatment of Aortic and Mitral Valve Disease","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Closed Joint-Stock Company NeoCor","has_results":false},{"nct_id":"NCT05668611","title":"Train the Trainer Curriculum to Scale up AI Supported Echo for RHD Screening in a Public Health System","phase":"NA","overall_status":"COMPLETED","enrollment_count":1628,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05211024","title":"A Long-term Follow up Study for Patients Who Participated in the GOAL Trial (GOAL-Post)","phase":"","overall_status":"COMPLETED","enrollment_count":1423,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05693545","title":"GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1004,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03346525","title":"Determining the Impact of Penicillin in Latent RHD: The GOAL Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":807,"lead_sponsor_name":"Children's National Research Institute","has_results":false},{"nct_id":"NCT02124109","title":"The Genetic Basis of Acquired Heart Disease in Africa","phase":"","overall_status":"COMPLETED","enrollment_count":736,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05682196","title":"Rituximab in Patients With Acute Rheumatic Fever","phase":"PHASE2","overall_status":"SUSPENDED","enrollment_count":234,"lead_sponsor_name":"African Academy of Methodology and Statistics","has_results":false},{"nct_id":"NCT05783375","title":"Accelerating Delivery of rheUmatic Heart Disease Preventive iNterventions in Northern Uganda","phase":"NA","overall_status":"RECRUITING","enrollment_count":221,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05502042","title":"Case Management and Peer Support Groups for Prophylaxis Adherence in Rheumatic Heart Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":209,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT04556188","title":"The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Helse Nord-Trøndelag HF","has_results":false},{"nct_id":"NCT05487469","title":"Thymosin α1 Use in Rheumatic Heart Disease Patients Undergoing Cardiac Surgery on Cardiopulmonary Bypass","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT06097585","title":"Gliflozins on HF in Regurgitant Rheumatic Heart","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03029117","title":"Effect of Rheumatic Heart Disease on Maternal and Fetal Outcomes","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT04704349","title":"Latest Imaging SPECT System Evaluation Phase 1","phase":"NA","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Centre Hospitalier Régional d'Orléans","has_results":false},{"nct_id":"NCT03991910","title":"The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT07078357","title":"Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT06696560","title":"Minimal Invasive Approaches For Aortic Valvular and Subvalvular Surgeries","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Yahia Abd almonem Sayed","has_results":false},{"nct_id":"NCT03926156","title":"RIvoraxaban in Mitral Stenosis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Rajaie Cardiovascular Medical and Research Center","has_results":false},{"nct_id":"NCT02474108","title":"Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium Enlargement","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Meshalkin Research Institute of Pathology of Circulation","has_results":false},{"nct_id":"NCT05618223","title":"Dapagliflozin Effect on Rheumatic Mitral Stenosis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Universitas Sebelas Maret","has_results":false},{"nct_id":"NCT03398733","title":"CPAP Treatment and Postoperative Outcomes in Patients With Rheumatic Valvular Heart Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Nanjing Medical University","has_results":false},{"nct_id":"NCT03156972","title":"Speckle Tracking for Timing of Surgical Operation in Severe Mitral Regurge","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Mohammed mahmoud mohammed othman","has_results":false},{"nct_id":"NCT06150274","title":"Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Helse Stavanger HF","has_results":false},{"nct_id":"NCT06952374","title":"Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Prince of Wales Hospital, Shatin, Hong Kong","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}